loadpatents
Patent applications and USPTO patent grants for Akashi; Koichi.The latest application filed is for "method and kit for predicting therapeutic effectiveness of chemotherapy for diffuse large b-cell lymphoma patients".
Patent | Date |
---|---|
Method And Kit For Predicting Therapeutic Effectiveness Of Chemotherapy For Diffuse Large B-cell Lymphoma Patients App 20200270703 - Miyawaki; Kohta ;   et al. | 2020-08-27 |
Anti-TIM-3 antibody Grant 10,550,181 - Takayanagi , et al. Fe | 2020-02-04 |
Method for treatment of blood tumor using anti-TIM-3 antibody Grant 9,958,446 - Takayanagi , et al. May 1, 2 | 2018-05-01 |
Anti-tim-3 Antibody App 20170088616 - TAKAYANAGI; Shin-ichiro ;   et al. | 2017-03-30 |
Anti-TIM-3 antibody Grant 9,556,270 - Takayanagi , et al. January 31, 2 | 2017-01-31 |
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody App 20160363595 - TAKAYANAGI; Shinichiro ;   et al. | 2016-12-15 |
Method for treatment of blood tumor using anti-TIM-3 antibody Grant 9,487,591 - Takayanagi , et al. November 8, 2 | 2016-11-08 |
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody App 20150284468 - TAKAYANAGI; Shinichiro ;   et al. | 2015-10-08 |
Method for treatment of blood tumor using anti-TIM-3 antibody Grant 9,103,832 - Takayanagi , et al. August 11, 2 | 2015-08-11 |
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody App 20140134639 - TAKAYANAGI; Shinichiro ;   et al. | 2014-05-15 |
Anti-tim-3 Antibody App 20140044728 - TAKAYANAGI; Shin-ichiro ;   et al. | 2014-02-13 |
Method for treatment of blood tumor using anti-TIM-3 antibody Grant 8,647,623 - Takayanagi , et al. February 11, 2 | 2014-02-11 |
Anti-TIM-3 antibody Grant 8,552,156 - Takayanagi , et al. October 8, 2 | 2013-10-08 |
Anti-tim-3 Antibody App 20120189617 - TAKAYANAGI; Shin-ichiro ;   et al. | 2012-07-26 |
Method For Treatment Of Blood Tumor Using Anti-tim-3 Antibody App 20120100131 - Takayanagi; Shinichiro ;   et al. | 2012-04-26 |
Mammalian myeloid progenitor cell subsets Grant 7,618,654 - Weissman , et al. November 17, 2 | 2009-11-17 |
Mammalian Myeloid Progenitor Cell Subsets App 20080131408 - Weissman; Irving L. ;   et al. | 2008-06-05 |
Mammalian myeloid progenitor cell subsets Grant 7,300,760 - Weissman , et al. November 27, 2 | 2007-11-27 |
Mammalian common lymphoid progenitor cell Grant 7,297,329 - Akashi , et al. November 20, 2 | 2007-11-20 |
Mammalian common lymphoid progenitor cell App 20050191284 - Akashi, Koichi ;   et al. | 2005-09-01 |
Mammalian common lymphoid progenitor cell Grant 6,908,763 - Akashi , et al. June 21, 2 | 2005-06-21 |
Mammalian myeloid progenitor cell subsets Grant 6,761,883 - Weissman , et al. July 13, 2 | 2004-07-13 |
Mammalian myeloid progenitor cell subsets App 20040132186 - Weissman, Irving L. ;   et al. | 2004-07-08 |
Mammalian myeloid progenitor cell subsets Grant 6,465,247 - Weissman , et al. October 15, 2 | 2002-10-15 |
Mammalian myeloid progenitor cell subsets App 20020086422 - Weissman, Irving L. ;   et al. | 2002-07-04 |
Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker Grant 5,821,108 - Akashi , et al. October 13, 1 | 1998-10-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.